CCRN
Income statement / Annual
Last year (2024), Cross Country Healthcare, Inc.'s total revenue was $1.34 B,
a decrease of 33.46% from the previous year.
In 2024, Cross Country Healthcare, Inc.'s net income was -$14.56 M.
See Cross Country Healthcare, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.34 B |
$2.02 B |
$2.80 B |
$1.68 B |
$836.42 M |
$822.22 M |
$816.48 M |
$865.05 M |
$833.54 M |
$767.42 M |
| Cost of Revenue |
$1.07 B
|
$1.57 B
|
$2.18 B
|
$1.30 B
|
$633.69 M
|
$618.22 M
|
$606.92 M
|
$636.46 M
|
$611.80 M
|
$570.06 M
|
| Gross Profit |
$274.25 M
|
$450.41 M
|
$624.46 M
|
$375.00 M
|
$202.73 M
|
$204.01 M
|
$209.56 M
|
$228.59 M
|
$221.74 M
|
$197.37 M
|
| Gross Profit Ratio |
0.2
|
0.22
|
0.22
|
0.22
|
0.24
|
0.25
|
0.26
|
0.26
|
0.27
|
0.26
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$246.31 M
|
$303.45 M
|
$0.00
|
$210.54 M
|
$170.64 M
|
$176.07 M
|
$175.73 M
|
$181.66 M
|
$170.21 M
|
$157.37 M
|
| Selling & Marketing Expenses |
$8.50 M
|
$11.50 M
|
$0.00
|
$9.50 M
|
$6.20 M
|
$7.90 M
|
$6.70 M
|
$7.60 M
|
$10.20 M
|
$4.90 M
|
| Selling, General & Administrative Expenses |
$254.81 M
|
$314.95 M
|
$324.21 M
|
$220.04 M
|
$176.84 M
|
$183.97 M
|
$182.43 M
|
$189.26 M
|
$180.41 M
|
$162.27 M
|
| Other Expenses |
$36.31 M
|
$22.74 M
|
$30.37 M
|
$15.65 M
|
$35.05 M
|
$35.75 M
|
$418.00 K
|
$155.00 K
|
$230.00 K
|
$306.00 K
|
| Operating Expenses |
$291.12 M
|
$337.70 M
|
$354.58 M
|
$235.70 M
|
$211.89 M
|
$219.72 M
|
$192.01 M
|
$197.61 M
|
$189.00 M
|
$169.34 M
|
| Cost And Expenses |
$1.36 B
|
$1.91 B
|
$2.53 B
|
$1.54 B
|
$845.58 M
|
$837.94 M
|
$798.93 M
|
$834.07 M
|
$800.80 M
|
$739.40 M
|
| Interest Income |
$2.05 M
|
$0.00
|
$10.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.19 M
|
$8.09 M
|
$14.39 M
|
$6.87 M
|
$2.89 M
|
$5.31 M
|
$5.65 M
|
$4.21 M
|
$6.11 M
|
$6.81 M
|
| Depreciation & Amortization |
$17.50 M
|
$18.35 M
|
$12.58 M
|
$9.45 M
|
$9.57 M
|
$11.18 M
|
$11.78 M
|
$10.17 M
|
$9.18 M
|
$8.07 M
|
| EBITDA |
$16.77 M |
$129.34 M |
$280.06 M |
$154.56 M |
$25.89 M |
$20.04 M |
-$761.00 K |
$18.69 M |
$41.32 M |
$35.09 M |
| EBITDA Ratio |
0.01
|
0.06
|
0.1
|
0.09
|
0.03
|
0.02
|
-0
|
0.02
|
0.05
|
0.05
|
| Operating Income Ratio |
-0.01
|
0.06
|
0.1
|
0.08
|
-0.01
|
-0.02
|
-0.02
|
0.01
|
0.01
|
0.03
|
| Total Other Income/Expenses Net |
$467.00 K
|
-$9.82 M
|
-$16.78 M
|
-$6.10 M
|
-$3.17 M
|
-$8.50 M
|
-$5.32 M
|
-$7.45 M
|
-$1.64 M
|
-$16.41 M
|
| Income Before Tax |
-$16.40 M
|
$102.89 M
|
$253.10 M
|
$133.21 M
|
-$12.33 M
|
-$24.21 M
|
-$18.20 M
|
$4.30 M
|
$4.55 M
|
$4.16 M
|
| Income Before Tax Ratio |
-0.01
|
0.05
|
0.09
|
0.08
|
-0.01
|
-0.03
|
-0.02
|
0
|
0.01
|
0.01
|
| Income Tax Expense |
-$1.84 M
|
$30.26 M
|
$67.12 M
|
$1.21 M
|
-$188.00 K
|
$31.73 M
|
-$2.48 M
|
-$34.50 M
|
-$4.19 M
|
-$794.00 K
|
| Net Income |
-$14.56 M
|
$72.63 M
|
$185.98 M
|
$132.00 M
|
-$12.96 M
|
-$57.71 M
|
-$16.95 M
|
$37.51 M
|
$7.97 M
|
$4.42 M
|
| Net Income Ratio |
-0.01
|
0.04
|
0.07
|
0.08
|
-0.02
|
-0.07
|
-0.02
|
0.04
|
0.01
|
0.01
|
| EPS |
-0.44 |
2.07 |
5.09 |
3.6 |
-0.34 |
-1.56 |
-0.48 |
1.07 |
0.25 |
0.14 |
| EPS Diluted |
-0.44 |
2.05 |
5.02 |
3.53 |
-0.34 |
-1.56 |
-0.48 |
1.01 |
0.15 |
0.14 |
| Weighted Average Shares Out |
$33.38 M
|
$35.16 M
|
$37.01 M
|
$36.69 M
|
$36.09 M
|
$35.82 M
|
$35.31 M
|
$35.02 M
|
$32.13 M
|
$31.51 M
|
| Weighted Average Shares Out Diluted |
$33.38 M
|
$35.48 M
|
$37.54 M
|
$37.39 M
|
$36.09 M
|
$35.82 M
|
$35.66 M
|
$36.17 M
|
$36.25 M
|
$32.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
